ConductScience.org, home

Trial · NCT02019316

BioSteel Supplementation and Performance

NCT02019316, Phase 1, Unknown, University of Western Ontario, Canada

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. BioSteel Supplementation and Performance. Trials, record NCT02019316. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02019316

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
BioSteel Supplementation and Performance
NCT number
NCT02019316
Status
Unknown
Phases
Phase 1
Enrollment
15 participants, estimated
Lead sponsor
University of Western Ontario, Canada
Conditions
Fatigue
Interventions
BioSteel Sports Drink, Isoenergetic Control
First posted
2013-12-24
Last updated
2013-12-24

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange from baseline in Muscular PowerBaseline and following each trial (1 day).Wingate test: Will be conducted using a cycle ergometer which electronically measures power (average, peak and decline). Resistance will be equal to 10% of subject body mass in kg.
SecondaryChange from baseline in Executive Function via Modified Stroop TestBaseline and after each trial (1 day).Modified Stroop test- a measurement of attentional fatigue and executive function, will be scored based on error rate and mean response time (Kane \& Kay, 1992).
SecondaryChange from baseline in anaerobic muscular power via Sitting Medicine Ball TossBaseline and after each trial (1 day).Sitting medicine ball toss using a standard 4kg medicine ball. Where the ball first lands will be measured as the total distance (recorded in cm.)
SecondaryChange from baseline in anaerobic muscular power via Standing Long JumpBaseline and after each trial (1 day).Standing long jump will be conducted from a standing start with feet together. The distance from the jumping line to the individuals heels will recorded as the total distance (recorded in cm.)
SecondaryChange from baseline in anaerobic muscular power via Vertical JumpBaseline and after each trial (1 day).Vertical jump will be conducted from a standing start. Without a pre-step individual will jump as a high as possible. Measurement is to the nearest cm.
SecondaryChange from baseline in muscular endurance via Bench PressBaseline and after each trial (1 day).Bench press repetitions of 150 lbs (including the barbell) will be performed at a rate of 25 repetitions per minute.
SecondaryChange from baseline in speed of processing via Trail Making Test Part BBaseline and after each trial (1 day).Trail Making Test Part B- a measurement of visual attention and speed of processing, will be scored on total time to completion (Sanchez-Cubillo et al., 2009).
SecondaryChange from baseline in subjective feeling of exertion via Rating of Perceived ExertionBaseline and after each trial (1 day)Ratings of perceived exertion: Will be assessed after each sprint interval trial and at the conclusion of muscular endurance and power testing via a Borg Scale (Noble et al., 1983).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers8

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1748109RESULTPubMed
6656563RESULTPubMed
7473239RESULTPubMed
9018517RESULTPubMed
9124069RESULTPubMed
12768487RESULTPubMed
15349784RESULTPubMed
20386134RESULTPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Stroop Color-Word TestSecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02019316

GET https://conductscience.org/api/trials/v1/NCT02019316/registered